Albemarle Maintains Its Prior Full-year Outlook Considerations, Which Are Based On Observed Lithium Market Price Scenarios
Portfolio Pulse from Benzinga Newsdesk
Albemarle maintains its full-year outlook but reduces its Specialties adjusted EBITDA outlook due to slower market rebound and higher logistics costs from the Middle East conflict. The company expects a charge of $0.9-$1.1 billion in Q3 2024.
July 31, 2024 | 8:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Albemarle maintains its full-year outlook but reduces its Specialties adjusted EBITDA outlook due to slower market rebound and higher logistics costs from the Middle East conflict. The company expects a charge of $0.9-$1.1 billion in Q3 2024.
The reduction in Specialties adjusted EBITDA outlook and the expected charge of $0.9-$1.1 billion in Q3 2024 are likely to negatively impact Albemarle's stock price in the short term. The higher logistics costs and slower market rebound are significant factors contributing to this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100